Collagen is the cornerstone of skin structure, directly influencing firmness, density, and resilience. As the main component of the dermis, it plays a decisive role in maintaining a youthful appearance. However, both intrinsic aging and environmental factors – particularly UV exposure – progressively alter collagen integrity, leading to visible signs such as wrinkles, loss of elasticity, and uneven skin texture. Today, targeting collagen remains a key driver for cosmetic innovation.
The dermis functions as the skin’s structural backbone, relying on a highly organized extracellular matrix. Fibroblasts regulate the production of essential components such as collagen (mainly types I and III) and elastin, ensuring mechanical strength and flexibility. Hyaluronic acid further supports hydration and tissue viscoelasticity. With aging, this balance is disrupted: fibroblast activity decreases, collagen fibers fragment, and the overall architecture becomes disorganized. These alterations are even more pronounced in photoaged skin, where cumulative environmental damage accelerates matrix degradation.
To effectively assess these changes, a multi-level scientific approach is essential. Early-stage investigations using 3D skin models and human skin explants enable detailed exploration of dermal remodeling. Histological techniques provide clear visualization of collagen distribution and structural alterations, offering valuable insights into ingredient efficacy at a mechanistic level.
Comparative immunostaining of type I collagen in the dermis of young and aged human skin. Structural changes associated with the aging process can be observed.
At the molecular scale, advanced profiling approaches help decode the biological pathways involved in skin aging. By analyzing gene and protein expression, these methods highlight the impact of cosmetic compounds on key processes such as extracellular matrix turnover, oxidative stress response, and inflammation, strengthening the scientific understanding of product performance.
In vivo, non-invasive technologies play a critical role in bridging biology and clinical outcomes. Raman spectroscopy provides direct insight into collagen molecular structure. Imaging techniques further enhance dermal visualization: SIAscopy reveals subsurface collagen distribution, while high-frequency ultrasound assesses dermal density and highlights features such as the subepidermal low echogenic band (SLEB), a recognized marker of photoaging. Optical coherence tomography (OCT) enables cross-sectional imaging of skin layers, and LC-OCT provides near-histological resolution of collagen fiber organization in real time. Complementary techniques such as confocal microscopy and multiphoton imaging offer additional high-contrast visualization of collagen architecture.
Comparative skin images obtained using 20 MHz ultrasound showing reduced dermal thickness and density associated with aging
Comparative LC-OCT images of dermal fibres on cheek showing altered fibres organization associated with aging
Beyond structural imaging, functional and clinical evaluations are essential to demonstrate meaningful benefits. Biomechanical measurements quantify changes in firmness, elasticity, and viscoelastic recovery, directly reflecting dermal matrix integrity. Clinical assessments – including wrinkle depth, sagging, and skin texture analysis – translate these biological effects into visible and measurable outcomes.
At Eurofins Cosmetics & Personal Care, this combination of ex vivo, in vitro, and in vivo approaches forms a comprehensive evaluation platform, integrating mechanistic insights with advanced imaging (e.g., SIAscope, OCT, LC-OCT, SLEB analysis) and clinical endpoints. This holistic strategy enables robust substantiation of collagen-related claims, supporting the development of high-performance anti-aging products backed by strong scientific evidence – from molecular mechanisms to visible results.
Expert grading and standardized scales reinforce the robustness of clinical interpretation.
Website: www.eurofins.com/cos
E-mail: Cosmetics@cpt.eurofinseu.com
